侯传伟

About

Dr. Hou Chuanwei (侯传伟) is currently a partner at Shanghai Hongfu Private Fund Management Co., Ltd. (上海鸿富私募基金管理有限公司), responsible for investment research on biopharmaceutical projects. He holds a PhD in medicinal chemistry from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and a bachelor's degree in pharmacy from the School of Pharmaceutical Sciences, Sun Yat-sen University. Before joining Hongfu Asset Management, he worked at the professional pharmaceutical investment firm Qianlong Investment, covering areas including innovative drugs, vaccines and R&D services. He led the team in completing investments in Zhuoyi Biology, Wangshan Wangshui, Xianlu Pharmaceutical, Allist (艾力斯, Ailisi) and others. After joining Hongfu Asset Management, as project lead he led and took part in investments in projects such as Yafei Biology and Hemei Pharmaceutical. Before working in investment, he was a BD specialist at Wowu Biology (我武生物), responsible for several new drug research projects.

Source (opens in a new tab)